Patents by Inventor Philip Clarke
Philip Clarke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12331057Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.Type: GrantFiled: October 16, 2023Date of Patent: June 17, 2025Assignee: Vertex Pharmaceuticals IncorporatedInventors: Upul Keerthi Bandarage, Cavan McKeon Bligh, Diane Boucher, Michael John Boyd, Michael Aaron Brodney, Michael Philip Clark, Veronique Damagnez, Lev Tyler Dewey Fanning, Robert Francis Fimognari, Gabrielle Simone Fleming, Kevin James Gagnon, Pedro Manuel Garcia Barrantes, Robert Daniel Giacometti, Simon Giroux, Ronald Lee Grey, Jr., Samantha Guido, Amy Beth Hall, Sarah Carol Hood, Dennis James Hurley, Mac Arthur Johnson, Jr., Peter Jones, Sarathy Kesavan, Mei-Hsiu Lai, Siying Liu, Adam Looker, Brad Maxwell, John Patrick Maxwell, Ales Medek, Philippe Marcel Nuhant, Kirk Alan Overhoff, Setu Roday, Stefanie Roeper, Steven M. Ronkin, Rupa Sawant, Yi Shi, Muna Shrestha, Marisa Sposato, Kathy Stavropoulos, Rebecca Jane Swett, Timothy Lewis Tapley, Qing Tang, Stephen Thomson, Jinwang Xu, Mariam Zaky, Kevin Michael Cottrell
-
Publication number: 20240336614Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.Type: ApplicationFiled: October 16, 2023Publication date: October 10, 2024Inventors: Upul Keerthi BANDARAGE, Cavan McKeon BLIGH, Diane BOUCHER, Michael John BOYD, Michael Aaron BRODNEY, Michael Philip CLARK, Veronique DAMAGNEZ, Lev Tyler Dewey FANNING, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon GIROUX, Ronald Lee GREY, JR., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James HURLEY, Mac Arthur JOHNSON, JR., Peter Jones, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam LOOKER, Brad MAXWELL, John Patrick MAXWELL, Ales MEDEK, Philippe Marcel NUHANT, Kirk Alan OVERHOFF, Setu RODAY, Stefanie ROEPER, Steven M. RONKIN, Rupa SAWANT, Yi SHI, Muna SHRESTHA, Marisa SPOSATO, Kathy STAVROPOULOS, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Qing TANG, Stephen THOMSON, Jinwang XU, Mariam ZAKY, Kevin Michael COTTRELL
-
Patent number: 11884672Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.Type: GrantFiled: May 13, 2020Date of Patent: January 30, 2024Assignee: Vertex Pharmaceuticals IncorporatedInventors: Upul Keerthi Bandarage, Cavan McKeon Bligh, Diane Boucher, Michael John Boyd, Michael Aaron Brodney, Michael Philip Clark, Veronique Damagnez, Lev Tyler Dewey Fanning, Robert Francis Fimognari, Gabrielle Simone Fleming, Kevin James Gagnon, Pedro Manuel Garcia Barrantes, Robert Daniel Giacometti, Simon Giroux, Ronald Lee Grey, Jr., Samantha Guido, Amy Beth Hall, Sarah Carol Hood, Dennis James Hurley, Mac Arthur Johnson, Jr., Peter Jones, Sarathy Kesavan, Mei-Hsiu Lai, Siying Liu, Adam Looker, Brad Maxwell, John Patrick Maxwell, Ales Medek, Philippe Marcel Nuhant, Kirk Alan Overhoff, Setu Roday, Stefanie Roeper, Steven M. Ronkin, Rupa Sawant, Yi Shi, Muna Shrestha, Marisa Sposato, Kathy Stavropoulos, Rebecca Jane Swett, Timothy Lewis Tapley, Qing Tang, Stephen Thomson, Jinwang Xu, Mariam Zaky, Kevin Michael Cottrell
-
Publication number: 20230339915Abstract: Novel compounds, compositions, and methods of using and preparing the same, which maybe useful for treating alpha-1 antitrypsin deficiency (AATD).Type: ApplicationFiled: April 2, 2021Publication date: October 26, 2023Inventors: Simon GIROUX, Michael Philip CLARK, Qing TANG, Philippe Marcel NUHANT, Peter JONES, David MESSERSMITH, Upul Keerthi BANDARAGE, Kevin Michael COTTRELL, Michael Aaron BRODNEY, Gabrielle Simone FLEMING, Jian WANG, Jinwang XU, Kevin Brett DANIEL, Michael John BOYD, Mark A. MORRIS, Nathan D. WAAL, Philip Noel COLLIER, Sarathy KESAVAN, Steven M. RONKIN, Hongbo DENG, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ
-
Publication number: 20230157999Abstract: Pyrano[4,3-b]indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD)Type: ApplicationFiled: April 2, 2021Publication date: May 25, 2023Inventors: Michael Philip CLARK, Simon GIROUX, Philip Noel COLLIER, Qing TANG, Nathan D. WAAL, Sarathy KESAVAN, Peter JONES, Michael Aaron BRODNEY, Wenxin GU, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, JR., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ, Kevin Michael COTTRELL
-
Publication number: 20230159502Abstract: Indole derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD).Type: ApplicationFiled: April 2, 2021Publication date: May 25, 2023Inventors: Simon GIROUX, Michael Philip CLARK, Michael Aaron BRODNEY, Philippe Marcel NUHANT, Emily Elizabeth ALLEN, Robert Francis FIMOGNARI, Jr., Mariam ZAKY, Michael John BOYD, David D. DEININGER, Hu ZHANG, Hongbo DENG, Philip Noel COLLIER, Brad MAXWELL, Nathan D. WAAL, Steven M. RONKIN, Jian WANG, Qing TANG, Gabrielle Simone FLEMING, Peter JONES, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ, Kevin Michael COTTRELL, Upul Keerthi BANDARAGE
-
Publication number: 20230159504Abstract: 7- or 8-hydroxy-isoquinoline and 7- or 8-hydroxy-quinoline derivatives as alpha-1-antitrypsin modulators for treating alpha-1-antitrypsin deficiency (AATD).Type: ApplicationFiled: April 2, 2021Publication date: May 25, 2023Inventors: Simon GIROUX, Michael Philip CLARK, Michael Aaron BRODNEY, Peter JONES, Michael Paul DENINNO, Wenxin GU, Qing TANG, Steven David STONE, Timothy J. SENTER, Zachary GALE-DAY, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ, Kevin Michael COTTRELL
-
Publication number: 20220119526Abstract: A biologics manufacturing process that connects the drug substance and drug product processes into an integrated, continuous process.Type: ApplicationFiled: January 27, 2020Publication date: April 21, 2022Applicant: AMGEN INC.Inventors: Subramanian GUHAN, Malhar R. AMBHAIKAR, Vincent CHAI, Sai Chakradhar PADALA, Nitin RATHORE, Zane SAREMI, Kenneth SHOEMAKER, Benjamin J. TILLOTSON, Balakumar THANGARAJ, Philip CLARK, Ashish SHARMA, Hann-Chung WONG, John E. THORUP
-
Patent number: 11248016Abstract: The invention may provide, in part, compounds for use as antiproliferative, chemotherapeutic, antiviral, cell sensitising or adjuvant agents, and pharmaceutical compositions including the compounds. The compounds may be for use in treating diseases and disorders related to cell proliferation such as cancer, or in treating diseases and disorder which are linked to aberrant control of protein synthesis, such as cancer, viral infection, muscle wasting, autistic spectrum disorders, Alzheimer's disease, Huntingdon's disease and Parkinson's disease.Type: GrantFiled: July 25, 2019Date of Patent: February 15, 2022Assignee: THE UNIVERSITY OF NOTTINGHAMInventors: Andrew Bottley, Christopher Hayes, Graham Seymour, Anna Grabowska, Philip Clarke
-
Patent number: 10868365Abstract: A portable common geometry non-linear antenna apparatus including a partially transparent housing defining a cavity, and a generally hemispherical antenna disposed within the cavity. The generally hemispherical antenna further includes an electrically conductive ground portion, an electrically conductive signal portion, an electrically insulating portion disposed between the electrically conductive ground and signal portions, and an electrically conducting mesh portion connected in electric communication with the signal portion. A first contact operationally connected to the ground portion and a second contact operationally connected to the signal portion. The electrically conductive mesh portion typically extends or bulges away from the electrically insulating portion to define a Faraday cage.Type: GrantFiled: January 2, 2019Date of Patent: December 15, 2020Inventor: Earl Philip Clark
-
Publication number: 20200361939Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.Type: ApplicationFiled: May 13, 2020Publication date: November 19, 2020Inventors: Upul Keerthi BANDARAGE, Cavan McKeon BLIGH, Diane BOUCHER, Michael John BOYD, Michael Aaron BRODNEY, Michael Philip CLARK, Veronique DAMAGNEZ, Lev Tyler Dewey FANNING, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon GIROUX, Ronald Lee GREY, Jr., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., Peter Jones, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam LOOKER, Brad MAXWELL, John Patrick MAXWELL, Ales MEDEK, Philippe Marcel NUHANT, Kirk Alan OVERHOFF, Setu RODAY, Stefanie ROEPER, Steven M. RONKIN, Rupa SAWANT, Yi SHI, Muna SHRESTHA, Marisa SPOSATO, Kathy STAVROPOULOS, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Qing TANG, Stephen THOMSON, Jinwang XU, Mariam ZAKY
-
Publication number: 20200212562Abstract: A portable common geometry non-linear antenna apparatus including a partially transparent housing defining a cavity, and a generally hemispherical antenna disposed within the cavity. The generally hemispherical antenna further includes an electrically conductive ground portion, an electrically conductive signal portion, an electrically insulating portion disposed between the electrically conductive ground and signal portions, and an electrically conducting mesh portion connected in electric communication with the signal portion. A first contact operationally connected to the ground portion and a second contact operationally connected to the signal portion. The electrically conductive mesh portion typically extends or bulges away from the electrically insulating portion to define a Faraday cage.Type: ApplicationFiled: January 2, 2019Publication date: July 2, 2020Inventor: Earl Philip Clark
-
Patent number: 10642291Abstract: A valve is provided and includes a bypass block defining a bypass flowpath fluidly communicable with main flowpaths, a member disposable within the bypass block to occupy and move between first and second positions, the member being configured to permit fluid flow through the bypass flowpath when occupying the first position and to block a portion of the bypass flowpath to thereby prevent fluid flow through the bypass flowpath when occupying the second position and an elastic element. The elastic element is coupled to the member and configured to bias the member in a biasing direction toward the second position responsive to a temperature of fluid flowing along the main flowpaths.Type: GrantFiled: August 22, 2013Date of Patent: May 5, 2020Assignee: HS MARSTON AEROSPACE LTDInventors: Sean L. Cameron, David Russell Scott, Stuart Anthony Astley, Nigel Philip Clark, Patrick James Jones
-
Patent number: 10428102Abstract: The invention may provide, in part, compounds for use as antiproliferative, chemotherapeutic, antiviral, cell sensitizing or adjuvant agents, and pharmaceutical compositions including the compounds. The compounds may be for use in treating diseases and disorders related to cell proliferation such as cancer, or in treating diseases and disorders which are linked to aberrant control of protein synthesis, such as cancer, viral infection, muscle wasting, autistic spectrum disorders, Alzheimer's disease, Huntingdon's disease and Parkinson's disease.Type: GrantFiled: April 7, 2015Date of Patent: October 1, 2019Assignee: THE UNIVERSITY OF NOTTINGHAMInventors: Andrew Bottley, Christopher Hayes, Graham Seymour, Anna Grabowska, Philip Clarke
-
Patent number: 10007027Abstract: An apparatus for detecting a storm, including a partially transparent housing defining a cavity and a suspended magnetic element positioned within the cavity. The magnetic element is rotatable in a first plane and pivotable in second plane and third planes, wherein the second plane is perpendicular to the first plane and the third plane is perpendicular to the first plane and perpendicular to the second plane. A rapid pivot of the magnetic element away from the pull of gravity signals a close proximity of a storm. A first sensor operationally connected to the magnetic element for measuring the deflection of the magnetic element, dampening fluid substantially fills the cavity, a second sensor positioned within the housing for measuring the degree to which the magnetic element is level, and a laser operationally connected to the magnetic element and positioned to emit a beam of light corresponding to the orientation of the magnetic element.Type: GrantFiled: June 30, 2011Date of Patent: June 26, 2018Inventor: E. Philip Clark
-
Patent number: 9477586Abstract: Memory controller circuitry may process the memory access requests by reordering the sequence of requests. Reordering the sequence of requests may decrease the power consumption of the memory controller and system memory associated with the memory controller. The memory controller may operate in at least an unconstrained power mode, a priority mode, and a constrained power mode. In the unconstrained power mode, the memory controller may process memory access requests at elevated and power consumption levels. In the priority mode, the memory controller may process memory access requests from select sources with reduced power consumption. In the constrained power mode, the memory controller may process all memory access requests at reduced power consumption levels. Capacitive-model based power monitoring circuitry may be used to monitor the interactions between the memory controller and the system memory to dynamically adjust the operating mode of the memory controller.Type: GrantFiled: November 3, 2011Date of Patent: October 25, 2016Assignee: Altera CorporationInventors: Sam Hedinger, Philip Clarke
-
Publication number: 20160183001Abstract: Systems and methods for the use of headphones are provided. The systems and methods can offer ease of carrying, comfort, and/or use of headphones, particularly portable headphones that provide for a user adjustment of an audio equalizer setting directly at the headphones for a desired audio data frequency/amplitude profile. Moreover, a combination of the concepts of user-controlled sound dynamics are provided at the headphone device through computerized pendant that is configured to alter sound dynamics directly through it's own software application without needing to control the sound dynamics at the audio source. This allows a user of the headphones to switch between audio devices while maintaining a desired set of sound dynamics in the form of preset or custom audio profiles.Type: ApplicationFiled: February 29, 2016Publication date: June 23, 2016Inventors: STEVEN MICHAEL LAMAR, PHILIP CLARK BUNCH
-
Publication number: 20150382096Abstract: Systems and methods for the use of headphones are provided. The systems and methods can offer ease of carrying, comfort, and/or use of headphones, particularly portable headphones that provide for a user adjustment of an audio equalizer setting directly at the headphones for a desired audio data frequency/amplitude profile. Moreover, a combination of the concepts of user-controlled sound dynamics are provided at the headphone device through computerized pendant that is configured to alter sound dynamics directly through it's own software application without needing to control the sound dynamics at the audio source. This allows a user of the headphones to switch between audio devices while maintaining a desired set of sound dynamics in the form of preset or custom audio profiles.Type: ApplicationFiled: June 25, 2014Publication date: December 31, 2015Inventors: STEVEN MICHAEL LAMAR, PHILIP CLARK BUNCH
-
Publication number: 20140054387Abstract: A valve is provided and includes a bypass block defining a bypass flowpath fluidly communicable with main flowpaths, a member disposable within the bypass block to occupy and move between first and second positions, the member being configured to permit fluid flow through the bypass flowpath when occupying the first position and to block a portion of the bypass flowpath to thereby prevent fluid flow through the bypass flowpath when occupying the second position and an elastic element. The elastic element is coupled to the member and configured to bias the member in a biasing direction toward the second position responsive to a temperature of fluid flowing along the main flowpaths.Type: ApplicationFiled: August 22, 2013Publication date: February 27, 2014Applicant: HS MARSTON AEROSPACE LTDInventors: Sean L. Cameron, David Russell Scott, Stuart Anthony Astley, Nigel Philip Clark, Patrick James Jones
-
Publication number: 20130160905Abstract: A method for producing a tempered martensitic heat resistant steel for high temperature applications at an application temperature of up to 650° C. and to a steel produced by the method. The use of the steel in the production of components for high temperature applications such as turbine blades or casings, bolting and boiler tubes, heat exchangers or other elements in power generation systems.Type: ApplicationFiled: June 10, 2011Publication date: June 27, 2013Applicant: TATA STEEL NEDERLAND TECHNOLOGY BVInventors: Urszula Alicja Sachadel, Peter Francis Morris, Philip Clarke, Cheng Liu